Colleen L. Channick
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Colleen L. Channick has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Ara A. Chrissian
Division of Pulmonary, Critical Care, Hyperbaric, and Sleep Medicine, Loma Linda University Health, Loma Linda, CA
2 shared publicationsCaralee Caplan-Shaw
Division of Pulmonary, Critical Care, and Sleep Medicine, School of Medicine, New York University, New York, New York
2 shared publications- Gaetane Michaud
New York University, New York, New York
2 shared publications Reza Ronaghi
Division of Pulmonary, Critical Care and Sleep Medicine, David Geffen School of Medicine at UCLA. Los Angeles, California
2 shared publicationsSamir S. Makani
Division of Pulmonary and Critical Care Medicine, University of California, San Diego, San Diego, California
2 shared publicationsVan K. Holden
Division of Pulmonary, Critical Care, and Sleep Medicine, University of Maryland School of Medicine, Baltimore, MD
2 shared publications
Latest Publications
- 18 September 2026
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 33 (4)
American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series
The American Association of Bronchology and Interventional Pulmonology (AABIP) Essential Knowledge in Interventional Pulmonology Series aims to provide clinicians with concise, up-to-date reviews of key topics in the field, presented on a 3-year rotating cycle. The 2025 series focused on advanced diagnostic bronchoscopy. In this article, we provide an update on the bronchoscopic approach to malignant disease, examining whether navigational bronchoscopy has closed the diagnostic gap with transthoracic needle biopsy for peripheral pulmonary lesions, how advanced bronchoscopic technologies enable integrated diagnosis and mediastinal staging workflows, and whether these clinical benefits translate into meaningful economic value. These reviews are designed to complement the Essential Knowledge in Interventional Pulmonology Lecture Series delivered at the 2025 AABIP Annual Conference, which is available for viewing on the AABIP website: https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series.
- 18 September 2026
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 33 (4)
American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series
The American Association of Bronchology and Interventional Pulmonology (AABIP) Essential Knowledge in Interventional Pulmonology Series aims to provide clinicians with concise, up-to-date reviews of key topics in the field, presented on a 3-year rotating cycle. The 2025 series focused on advanced diagnostic bronchoscopy. In this article, we provide an update on the bronchoscopic approach to malignant disease, examining whether navigational bronchoscopy has closed the diagnostic gap with transthoracic needle biopsy for peripheral pulmonary lesions, how advanced bronchoscopic technologies enable integrated diagnosis and mediastinal staging workflows, and whether these clinical benefits translate into meaningful economic value. These reviews are designed to complement the Essential Knowledge in Interventional Pulmonology Lecture Series delivered at the 2025 AABIP Annual Conference, which is available for viewing on the AABIP website: https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series.
- 26 November 2025
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 33 (1)
American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series
The American Association of Bronchology and Interventional Pulmonology (AABIP) Essential Knowledge in Interventional Pulmonology Series aims to provide clinicians with concise, up-to-date reviews of key topics in the field, presented on a 3-year rotating cycle. The 2024 series focused on therapeutic bronchoscopy. In this article, we provide an update on curative-intent bronchoscopy for centrally located early-stage lung cancer, including a review of bronchoscopic imaging modalities for disease detection and current management techniques. These reviews are designed to complement the Essential Knowledge in Interventional Pulmonology Lecture Series delivered at the 2024 AABIP Annual Conference, which is available for viewing on the AABIP website: https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series
- 26 November 2025
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 33 (1)
American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series
The American Association of Bronchology and Interventional Pulmonology (AABIP) Essential Knowledge in Interventional Pulmonology Series aims to provide clinicians with concise, up-to-date reviews of key topics in the field, presented on a 3-year rotating cycle. The 2024 series focused on therapeutic bronchoscopy. In this article, we provide an update on curative-intent bronchoscopy for centrally located early-stage lung cancer, including a review of bronchoscopic imaging modalities for disease detection and current management techniques. These reviews are designed to complement the Essential Knowledge in Interventional Pulmonology Lecture Series delivered at the 2024 AABIP Annual Conference, which is available for viewing on the AABIP website: https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series
- 20 December 2024
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 32 (1)
American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series
The goal of the American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series is to provide clinicians with concise, up-to-date reviews of important topics in the field of interventional pulmonology. This 3-year alternating rotation of primary topics will start with a focus on selected topics in malignant pleural disease. In this article, we update the reader on malignant pleural effusion in 3 parts: part 1—diagnosis, focusing on imaging and fluid biomarkers; part 2—management, with review of multimodal approaches, cost considerations, and evolving targeted therapies; and part 3—pleural mesothelioma. These reviews complement the Essential Knowledge in Interventional Pulmonology Lecture Series presented at the 2023 AABIP Annual Conference, available for viewing on the AABIP website (https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series).
- 20 December 2024
- Published by Wolters Kluwer Health in Journal of Bronchology & Interventional Pulmonology
- Vol. 32 (1)
American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series
The goal of the American Association of Bronchology and Interventional Pulmonology Essential Knowledge in Interventional Pulmonology Series is to provide clinicians with concise, up-to-date reviews of important topics in the field of interventional pulmonology. This 3-year alternating rotation of primary topics will start with a focus on selected topics in malignant pleural disease. In this article, we update the reader on malignant pleural effusion in 3 parts: part 1—diagnosis, focusing on imaging and fluid biomarkers; part 2—management, with review of multimodal approaches, cost considerations, and evolving targeted therapies; and part 3—pleural mesothelioma. These reviews complement the Essential Knowledge in Interventional Pulmonology Lecture Series presented at the 2023 AABIP Annual Conference, available for viewing on the AABIP website (https://aabip.memberclicks.net/essential-knowledge-in-interventional-pulmonology-series).
- 16 October 2024
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 31 (1) , 19-27
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics
Purpose of review: Biopsy tools have been essential in improving the diagnostic accuracy of bronchoscopic procedures. Of these tools, cryobiopsy has emerged as a promising technique for diagnosing thoracic diseases. This review summarizes the existing data comparing cryobiopsies to other mechanical biopsy methods for sampling endobronchial, parenchymal, and mediastinal targets. Recent findings: Initially adopted for managing airway stenoses, the use of cryoprobes has expanded to diagnosing endobronchial lesions, parenchymal opacities, and mediastinal lymph node pathologies. Studies have demonstrated that cryobiopsy offers a higher diagnostic yield than forceps biopsy alone. By leveraging the Joule-Thomson effect to freeze and collect larger tissue samples compared to traditional methods, cryobiopsy improves diagnostic accuracy and helps in better characterizing the nature of the lesions. While the risk of complications, such as pneumothorax and hemorrhage are comparable to, or higher than traditional biopsy methods, cryobiopsy's enhanced diagnostic capabilities make it a valuable tool in the assessment of pulmonary disease. Summary: Compared with other mechanical biopsy techniques, cryoprobe biopsies significantly enhance the diagnostic yield for endobronchial lesions, interstitial lung disease, pulmonary nodules, and mediastinal lymph nodes.
- 16 October 2024
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 31 (1) , 19-27
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics
Purpose of review: Biopsy tools have been essential in improving the diagnostic accuracy of bronchoscopic procedures. Of these tools, cryobiopsy has emerged as a promising technique for diagnosing thoracic diseases. This review summarizes the existing data comparing cryobiopsies to other mechanical biopsy methods for sampling endobronchial, parenchymal, and mediastinal targets. Recent findings: Initially adopted for managing airway stenoses, the use of cryoprobes has expanded to diagnosing endobronchial lesions, parenchymal opacities, and mediastinal lymph node pathologies. Studies have demonstrated that cryobiopsy offers a higher diagnostic yield than forceps biopsy alone. By leveraging the Joule-Thomson effect to freeze and collect larger tissue samples compared to traditional methods, cryobiopsy improves diagnostic accuracy and helps in better characterizing the nature of the lesions. While the risk of complications, such as pneumothorax and hemorrhage are comparable to, or higher than traditional biopsy methods, cryobiopsy's enhanced diagnostic capabilities make it a valuable tool in the assessment of pulmonary disease. Summary: Compared with other mechanical biopsy techniques, cryoprobe biopsies significantly enhance the diagnostic yield for endobronchial lesions, interstitial lung disease, pulmonary nodules, and mediastinal lymph nodes.
- Open Access
- 29 January 2024
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 75 (1) , 263-276
Interventional Pulmonology: Extending the Breadth of Thoracic Care
Interventional pulmonary medicine has developed as a subspecialty focused on the management of patients with complex thoracic disease. Leveraging minimally invasive techniques, interventional pulmonologists diagnose and treat pathologies that previously required more invasive options such as surgery. By mitigating procedural risk, interventional pulmonologists have extended the reach of care to a wider pool of vulnerable patients who require therapy. Endoscopic innovations, including endobronchial ultrasound and robotic and electromagnetic bronchoscopy, have enhanced the ability to perform diagnostic procedures on an ambulatory basis. Therapeutic procedures for patients with symptomatic airway disease, pleural disease, and severe emphysema have provided the ability to palliate symptoms. The combination of medical and procedural expertise has made interventional pulmonologists an integral part of comprehensive care teams for patients with oncologic, airway, and pleural needs. This review surveys key areas in which interventional pulmonologists have impacted the care of thoracic disease through bronchoscopic intervention.
- 29 January 2024
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 75 (1) , 263-276
Open AccessInterventional Pulmonology: Extending the Breadth of Thoracic Care
Interventional pulmonary medicine has developed as a subspecialty focused on the management of patients with complex thoracic disease. Leveraging minimally invasive techniques, interventional pulmonologists diagnose and treat pathologies that previously required more invasive options such as surgery. By mitigating procedural risk, interventional pulmonologists have extended the reach of care to a wider pool of vulnerable patients who require therapy. Endoscopic innovations, including endobronchial ultrasound and robotic and electromagnetic bronchoscopy, have enhanced the ability to perform diagnostic procedures on an ambulatory basis. Therapeutic procedures for patients with symptomatic airway disease, pleural disease, and severe emphysema have provided the ability to palliate symptoms. The combination of medical and procedural expertise has made interventional pulmonologists an integral part of comprehensive care teams for patients with oncologic, airway, and pleural needs. This review surveys key areas in which interventional pulmonologists have impacted the care of thoracic disease through bronchoscopic intervention.
- 2 May 2022
- Published by Oxford University Press (OUP)
- p. A4203
Pneumonitis Following Intrapleural Administration of Povidone-Iodine for Pleurodesis
- 2 May 2022
- Published by Oxford University Press (OUP)
- p. A4203
Pneumonitis Following Intrapleural Administration of Povidone-Iodine for Pleurodesis
- Open Access
- 8 October 2020
- Published by Oxford University Press (OUP) in ATS Scholar
- Vol. 1 (4) , 416-435
ATS Core Curriculum 2020. Adult Pulmonary Medicine
The American Thoracic Society Core Curriculum updates clinicians annually in adult and pediatric pulmonary disease, medical critical care, and sleep medicine in a 3- to 4-year recurring cycle of topics. The topics of the 2020 Pulmonary Core Curriculum include pulmonary vascular disease (submassive pulmonary embolism, chronic thromboembolic pulmonary hypertension, and pulmonary hypertension) and pulmonary infections (community-acquired pneumonia, pulmonary nontuberculous mycobacteria, opportunistic infections in immunocompromised hosts, and coronavirus disease [COVID-19]).
- 8 October 2020
- Published by Oxford University Press (OUP) in ATS Scholar
- Vol. 1 (4) , 416-435
Open AccessATS Core Curriculum 2020. Adult Pulmonary Medicine
The American Thoracic Society Core Curriculum updates clinicians annually in adult and pediatric pulmonary disease, medical critical care, and sleep medicine in a 3- to 4-year recurring cycle of topics. The topics of the 2020 Pulmonary Core Curriculum include pulmonary vascular disease (submassive pulmonary embolism, chronic thromboembolic pulmonary hypertension, and pulmonary hypertension) and pulmonary infections (community-acquired pneumonia, pulmonary nontuberculous mycobacteria, opportunistic infections in immunocompromised hosts, and coronavirus disease [COVID-19]).
- Open Access
SAFETY AND DIAGNOSTIC YIELD OF TRANSBRONCHIAL LUNG CRYOBIOPSY IN THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE
- 1 December 2018
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
- Vol. 39 (06) , 731-746
Benign Central Airway Obstruction
Benign central airway obstruction (CAO) is responsible for significant morbidity due to dyspnea and impaired quality of life. While iatrogenic causes, including stenosis after endotracheal intubation, tracheostomy tube placement, and surgery, account for the majority of cases of benign CAO, there are a multitude of other causes including infections, inflammatory disorders, extrinsic compression, benign endobronchial tumors, and tracheobronchomalacia. The approach to management depends on the underlying process responsible for the disorder and may include systemic therapy, endoscopic therapy, and surgery. In this review, we aim to provide a general overview of the presentation, evaluation, and management of nonmalignant CAO followed by a more in-depth review of several of the more common causes of this disorder.
- 1 December 2018
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
- Vol. 39 (06) , 731-746
Benign Central Airway Obstruction
Benign central airway obstruction (CAO) is responsible for significant morbidity due to dyspnea and impaired quality of life. While iatrogenic causes, including stenosis after endotracheal intubation, tracheostomy tube placement, and surgery, account for the majority of cases of benign CAO, there are a multitude of other causes including infections, inflammatory disorders, extrinsic compression, benign endobronchial tumors, and tracheobronchomalacia. The approach to management depends on the underlying process responsible for the disorder and may include systemic therapy, endoscopic therapy, and surgery. In this review, we aim to provide a general overview of the presentation, evaluation, and management of nonmalignant CAO followed by a more in-depth review of several of the more common causes of this disorder.